Near-roadway air pollution associated with COVID-19 severity and mortality - Multiethnic cohort study in Southern California.


Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
12 2021
Historique:
received: 09 06 2021
revised: 04 08 2021
accepted: 01 09 2021
pubmed: 11 9 2021
medline: 7 10 2021
entrez: 10 9 2021
Statut: ppublish

Résumé

Air pollution exposure has been associated with increased risk of COVID-19 incidence and mortality by ecological analyses. Few studies have investigated the specific effect of traffic-related air pollution on COVID-19 severity. To investigate the associations of near-roadway air pollution (NRAP) exposure with COVID-19 severity and mortality using individual-level exposure and outcome data. The retrospective cohort includes 75,010 individuals (mean age 42.5 years, 54% female, 66% Hispanic) diagnosed with COVID-19 at Kaiser Permanente Southern California between 3/1/2020-8/31/2020. NRAP exposures from both freeways and non-freeways during 1-year prior to the COVID-19 diagnosis date were estimated based on residential address history using the CALINE4 line source dispersion model. Primary outcomes include COVID-19 severity defined as COVID-19-related hospitalizations, intensive respiratory support (IRS), intensive care unit (ICU) admissions within 30 days, and mortality within 60 days after COVID-19 diagnosis. Covariates including socio-characteristics and comorbidities were adjusted for in the analysis. One standard deviation (SD) increase in 1-year-averaged non-freeway NRAP (0.5 ppb NO Data from this multiethnic cohort suggested that NRAP, particularly non-freeway exposure in Southern California, may be associated with increased risk of COVID-19 severity and mortality among COVID-19 infected patients. Future studies are needed to assess the impact of emerging COVID-19 variants and chemical components from freeway and non-freeway NRAP.

Sections du résumé

BACKGROUND
Air pollution exposure has been associated with increased risk of COVID-19 incidence and mortality by ecological analyses. Few studies have investigated the specific effect of traffic-related air pollution on COVID-19 severity.
OBJECTIVE
To investigate the associations of near-roadway air pollution (NRAP) exposure with COVID-19 severity and mortality using individual-level exposure and outcome data.
METHODS
The retrospective cohort includes 75,010 individuals (mean age 42.5 years, 54% female, 66% Hispanic) diagnosed with COVID-19 at Kaiser Permanente Southern California between 3/1/2020-8/31/2020. NRAP exposures from both freeways and non-freeways during 1-year prior to the COVID-19 diagnosis date were estimated based on residential address history using the CALINE4 line source dispersion model. Primary outcomes include COVID-19 severity defined as COVID-19-related hospitalizations, intensive respiratory support (IRS), intensive care unit (ICU) admissions within 30 days, and mortality within 60 days after COVID-19 diagnosis. Covariates including socio-characteristics and comorbidities were adjusted for in the analysis.
RESULT
One standard deviation (SD) increase in 1-year-averaged non-freeway NRAP (0.5 ppb NO
CONCLUSIONS
Data from this multiethnic cohort suggested that NRAP, particularly non-freeway exposure in Southern California, may be associated with increased risk of COVID-19 severity and mortality among COVID-19 infected patients. Future studies are needed to assess the impact of emerging COVID-19 variants and chemical components from freeway and non-freeway NRAP.

Identifiants

pubmed: 34507232
pii: S0160-4120(21)00487-6
doi: 10.1016/j.envint.2021.106862
pmc: PMC8416551
pii:
doi:

Substances chimiques

Air Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106862

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES007048
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES029963
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA229110
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Zhanghua Chen (Z)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

Brian Z Huang (BZ)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.

Margo A Sidell (MA)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.

Ting Chow (T)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.

Sandrah P Eckel (SP)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

Nathan Pavlovic (N)

Sonoma Technology, Petaluma, CA, United States.

Mayra P Martinez (MP)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.

Fred Lurmann (F)

Sonoma Technology, Petaluma, CA, United States.

Duncan C Thomas (DC)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

Frank D Gilliland (FD)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

Anny H Xiang (AH)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States. Electronic address: anny.h.xiang@kp.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH